The funding round would double Kiwi startup’s previous valuation of $1.6 billion.
The startup that was trying to design plants to manufacture life-saving medicines has pulled the plug.
The Series A investment will help commercialise the medical device company’s portable photon-counting CT scanners in the US and NZ.
The money will go towards a pilot plant to scale its pioneering sustainable Celluspheres technology.
The startup is close to securing a strategic US investor that would allow the co-founders to sidestep local VC seed money.
Kiwi entrepreneur James Colley has started a mental health platform offering world-first AI video therapy with intelligent crisis alerts.
Venture capitalists name their picks of the startups most likely to make good progress this year.
From AI to social media, humanoid robots, and data sovereignty, tech in 2026 is set to explode.
Sandra Maclean started the business to automate school lunches, and now serves more than 560 schools around the country.
Board members also announced for new NZ Institute for Advanced Technology.